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Abstract 
The glucosinolate-myrosinase system in plants has been well studied over the years while 
relatively little research has been undertaken on the bacterial metabolism of glucosinolates. 
The products of myrosinase based glucosinolate hydrolysis in the human gut are important to 
health particularly the isothiocyanates as they are shown to have anticancer properties as well 
as other beneficial roles in human health. This review is concerned with the bacterial 
metabolism of glucosinolates but is not restricted to the human gut. Isothiocyanate production 
and nitrile formation are discussed together with the mechanisms of the formation of these 
compounds. Side chain modification of the methylsulfinylalkyl glucosinolates is reviewed 
and the implications for bioactivity of the resultant products is also discussed.  
Introduction 
During the cooking process of cruciferous vegetables, myrosinase activity and associated 
protein specifier proteins are usually destroyed unless strict cooking times are adhered to [1].  
Despite the thermal destruction of plant myrosinase activity the intake of cooked Brassica 
vegetables still results in the formation of bioactive isothiocyanates (ITCs) and nitriles which 
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arise from the metabolism of glucosinolates (GSLs) by the human gut microbiota. While 
there is a great deal of information concerning the beneficial effects of GSLs hydrolysis 
products on human health  [2–6] very little is known about the importance of the gut 
microbiota in generating these bioactive GSL products. Generally there has been little 
research into the metabolism of GSLs by bacteria particularly those of human origin.The lack 
of intensity of research into this area of GSLs is surprising as the human gut microbiota acts 
as a gateway for the formation of these key anticancer metabolites.  In order to review the 
topic, bacteria of extraintestinal origin are also discussed to generate a wider picture of 
bacterial myrosinases. Table 1 shows work in relation to animal and intestinal models while 
Table 2 details the work that has been carried out with pure bacterial cultures and includes 
where known,  the GSL substrates and their identified products.  
 
Isothiocyanate production 
In general the natural origins of ITCs are from the myrosinase catalyzed hydrolysis (Figure 1) 
of GSLs [7]. Marine organisms are also known to produce ITCs such as the diterpenoids 10-
epi-kalihinol I and 5-10-bisiosthiocyanato kalihinol G which have been shown to be 
biologically active [8].  The functional activity of the ITCs resides in the electrophilic nature 
of the carbon atom of the –N=C=S group which is able to undergo addition reactions with 
various nucleophiles [9, 10]. With amines, thioureas are formed while with sulfhydryl groups 
dithiocarbamates are the products [9, 10]. Since the diet is complex with a myriad of small 
molecules it is likely that ITCs react with many nucleophiles and not just with amines or 
sulfhydryls. The metabolism of ITCs in animal and human cells is via the glutathione 
pathway and is reviewed by other authors in this special edition. To maximise the benefits of 
ITCs it is of importance to understand how the human gut microbiota metabolises GSLs to 
ITCs and to what extent these ITCs are further metabolised to form other products that may 
be more or less bioactive. The gut bacteria play a key role in generating ITCs but these are 
not always the only end products. Various microbiological studies examining GSL 
metabolism have been carried out using animals with modified diets and specific microbiotas 
as well as in vitro model fermentation systems inoculated with fecal or cecal bacteria (Table 
1). The biotransformation studies with  isolated individual bacterial cultures are listed in 
Table 2.  The formation of goiter is a known phenomenon associated with a high intake of 
cruciferous vegetables in farm animals and humans [11]. One of the first goitrogens to be 
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discovered was 5-ethenyl-1,3-oxazolidine-2-thione which is derived from 2(R)-hydroxy-3-
butenylglucosinolate (progoitrin) [12] and was given the name goitrin [13]. Eventually the 
link between bacterial GSL metabolism and production of  goitrin from progoitrin was 
established [14].  In this study various fecal isolates were tested against progoitrin (Table 2) 
and Paracolobactrum aerogenoides was found to be the most active degrader.  The 
myrosinase activity  was also demonstrated in it’s  cell-free protein extract. Further evidence 
for the involvement of bacteria in GSL metabolism came from work with a Lactobacillus 
strain (LEM220) which was able to degrade GSLs [15] (Table 1). Rats fed a GSL-rich diet 
with a Lactobacillus LEM220 supplement developed goiter in comparison to controls which 
also confirmed the authors previous work [16]. Further investigations revealed that 
gnotobiotic rats associated with E. coli (EM0) or Bacteroides vulgatus (BV8H1) on a rape-
seed meal diet developed goiter thus implicating activity of GSL metabolising bacteria [17]. 
As part of a screen for GSL metabolizing bacteria from human intestinal microbiota,  B. 
thetaiotaomicron was isolated and found to convert sinigrin to allylisothiocyanate [18]. This 
isolate was tested in gnotobiotic rats supplemented with sinigrin and it was found that 
allylisothiocyanate was produced in the digestive system, thus for the first time linking GSL 
metabolism with a specific bacterium [19].   
Other workers have investigated rat cecal microbiota with a combination of glucoraphanin 
and bacterial growth media [20]. Here it was found that the rat cecal microbiota produced 
sulforaphane from GSL but only when supplemented with MRS, the media that supports the 
growth of Lactobacilli. Pretreatment of the rats with glucoraphanin prior to obtaining the 
cecal contents increased the ex-vivo conversion of GSL to ITC suggesting induction of 
bacterial myrosinase activity. 
Brabban and Edwards [21] carried out an extensive study testing some 192 laboratory strains 
for their ability to metabolise sinigrin. All bacteria that degraded sinigrin in this study were 
Gram positive and included members of Streptomyces, Bacillus and Staphylococcus derived 
from different sources (river Mersey, contaminated soil and mushroom compost), however, 
the products of GLS metabolism by these bacteria were not identified. One of the most well-
studied bacterial strains of human gut origin is the Gram positive Lactobacillus agilis R16 
isolated by Palop et al [22] which produces allylisothiocyanate from sinigrin. The authors 
could demonstrate myrosinase activity with intact cells but not with cell-free protein extracts. 
Subsequent  studies [23, 24] with L. agilis R16 showed similar results with sinigrin except 
that allylnitrile was also a product. This study was expanded to include glucotropaoelin, 
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gluconasturtiin, glucoraphanin, glucoerucin and glucoiberin. The activity of L. agilis R16 
with these GSL substrates showed a degree of substrate specificity as neither glucoraphanin 
nor glucoiberin were metabolised while gluconasturtiin produced only an ITC. Glucoerucin 
and glucotropaoelin like sinigrin wewre converted to  ITCs and nitriles [23, 24]. Again it was 
not possible to demonstrate myrosinase activity with cell-free protein extracts. Further studies 
were carried out using two bacterial strains Enterococcus casseliflavus CP1 and Eschericha 
coli VL8 that originated from human fecal material [23, 24]. E. coli VL8 was able to 
metabolise all the GSLs tested (Table 2) to both nitriles and ITCs in contrast to L. agilis R16 
which could not metabolise glucoraphanin or glucoiberin. E. casseliflavus CP1 was able to 
metabolise all GSLs tested to nitriles and ITCs with the exception of glucoraphanin and 
glucoiberin where only trace amounts of ITCs and nitriles were observed. As with L. agilis 
R16, all attempts to identify in vitro myrosinase activity in E. casseliflavus CP1 and E. coli 
VL8 were unsuccessful. Mullaney et al [25] carried out a study comparing lactic acid bacteria 
with Enterobacteriaceae and in all cases the products of GSL metabolism were nitriles and 
not ITCs. In this study glucoraphanin and glucoiberin were used and it was found that 
methylsulfinyl group of the side chain underwent reduction to the methylthio form and this is 
discussed in more detail later. A study by Lai et al [26] investigated the hydrolysis of 
glucoraphanin by various Lactobacilli in culture media and in all cases the corresponding 
nitrile was the major metabolic product. Three Bifidobacteria strains (B. pseudocatenulatum, 
B. adolescentis, B. longum) were examined [27] for their ability to biotransform GSLs. All 
three strains were able to metabolise sinigrin during fermentation while B. adolescentis also 
tested positive for glucotropaoelin metabolism. In the case of B. adolescentis, the products of 
fermentation were allylnitrile and benzylnitrile while there is less information on the products 
from B. pseudocatenulatum and B. longum. The authors carried out further work examining a 
cell-free protein extract from B. adolescentis and found myrosinase activity with the 
formation of allylisothiocyanate. Activation by ascorbate was marginal in comparison to 
plant myrosinases [7]. Attempts to repeat this work with these Bifidobacteria strains (RIKEN, 
Japan Collection of Microorganisms) was not successful in our hands (unpublished data) and 
may indicate that this trait is either unstable over a period of time or requires an unknown 
trigger that induces the biosynthesis of the myrosinases in these bacteria.  
Luciano et al [28] screened a number of bacteria for their ability to degrade sinalbin and 
found a various strains including Lactobacillus curvatus, Lactobacillus plantarum, 
Pediococcus pentosaceus, Staphylococcus carnosus, Staphylococcus  aureus  and E. coli 
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0157:H7 to be degraders with the latter being the most active.  Further studies involved 
screening a variety of bacteria including  E. coli 0157:H7 with sinigrin as a substrate with all 
strains producing allylisothiocyanate [29].  More recent work with the GSL metabolising E. 
coli 0157:H7 identified genes bglA and ascbB encoding 6-phospho-β-glucosidases [30]. 
Following gene disruption, the sinigrin degrading ability of this organism was substantially 
reduced. In order to confirm the functional role of these two genes it would be desirable to 
complement or overexpress these enzymes in the deletion strains.  
Recently an isolate from the Brassica microbiome has been identified as Enterobacter 
cloacae  KS50 and was shown to have myrosinase activity in cell-free protein extracts 
[31].The first bacterial myrosinase purification was carried out by Tani et al [32] from E. 
cloacae  506 [33]. The myrosinase was purified to homogeneity by classical chromatography 
techniques with a molecular weight of 61 kDa. Since this early study only one other bacterial 
myrosinase has been purified from a Citrobacter species (Citrobacter Wye1) [34] which has 
a molecular weight of 66 kDa and was shown to belong to the glycoside hydrolase family 3 
(GH3) β-O-glucosidases. Cell-free protein extracts produced ITCs although during 
fermentation, another product was detected but its identity was not established. The 
Citrobacter Wye1 myrosinase has been cloned and successfully expressed in E.coli and was 
shown to be a fully functional enzyme [35].  
Nitrile formation  
Cruciferous plants can possess specifier proteins namely epithiospecifier protein (ESP), 
thiocyanate forming protein (TFP) and  nitrile specifier protein (NSP) which direct the 
myrosinase catalyzed hydrolysis of GSLs to nitriles, epithionitriles and thiocyanates 
(Figure1)  [36]. As part of investigations into the mechanism of these specifier proteins it has 
been established that ferrous ions play a key role within the active site of the protein during 
catalysis [37]. While nitriles are readily observed during the hydrolysis of GSLs in 
fermentation, so far no bacterial specifier proteins have been found/or investigated that 
promote the formation of nitriles. Interestingly an epithionitrile (ETN) has been observed in 
only one study  [38] (Table 1). In this particular case the substrate was not an intact GSL but 
DS-sinigrin. As far as we are aware TFP, NSP and ESP like proteins have not been 
investigated for their ability to modify the products of GSLs or DS-GSLs in bacterial 
systems. Sulfatases have been identified in many bacteria while few have been cloned and 
characterized [39, 40]. A detailed study examining the metabolism of five DS-GSLs in  
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bacterial fermentations has recently been reported [24] where it was shown that specific 
strains of E. coli VL8, L. agilis R16 and E. casseliflavus CP1 can utilize DS-GSLs as a 
carbon source and produce nitriles. L. agilis R16 and E. casseliflavus CP1 however, could not 
metabolise DS-glucoraphanin while the former was also unable to utilize DS-gluconasturtiin. 
E. coli VL8 could metabolise all DS-GSLs tested to their nitrile derivatives. Another study 
has shown that a recombinant β-O-glucosidase from Caldocellum saccharolyticum was able 
to transform a number of DS-GSLs to their corresponding nitriles in the absence of ferrous 
ions [41]. This suggests that the origin of nitriles during the fermentation of GSLs may well 
be a result of desulfation followed by hydrolysis (Figure 2). It is known that plant 
myrosinases can direct hydrolysis towards nitriles in the presence of ferrous ions without a 
requirement for a specifier protein [42][43]. A study examining GSLs incubated with the 
resting cells of E. coli VL8 indicated that the presence of ferrous ions shifted hydrolysis away 
from ITCs towards nitriles [24] suggesting a ferrous ion dependency.  
Other work has also shown that a recombinant β-O-glucosidase  (bgl4) was able to hydrolyse 
DS-gluconasturtiin to phenethylnitrile without the presence of ferrous ions and on the 
contrary these ions if present inhibited the hydrolysis [44]. The generation of nitriles from  
DS-GSLs following hydrolysis by a β-O-glucosidase is likely due to the spontaneous 
decomposition of the thiohyroxamic acid without a need for ferrous ions[45][46].  In order to 
understand nitrile production during GSL hydrolysis further detailed work is required, 
particularly the role of ferrous or other metal ion species. In this respect the composition of 
fermentation media is of importance as the presence of metal ions here can potentially 
influence the outcome of GSL hydrolysis. Also the observation of an ETN in one study with 
DS-sinigrin [38] requires following up as the presence of ferrous ions are unlikely to be the 
only factor in the generation of this nitrile derivative. The fact that amines can be produced 
during fermentations suggests the presence of bacterial nitrile reductases [47]. These are a 
relatively new class of enzyme and one has been recently cloned and expressed from E. coli 
K-12 and shown to reduce 7-cyano-7-deazaguanine to amine 7-amino-methyl-7-
deazaguanine but has limited substrate specificity [48]. Whether or not bacterial nitrile 
reductases exist for GSL derived nitriles remains an open question. Nitrilases are well known 
[49] and it is possible that GSL derived nitriles are further hydrolysed to carboxylic acids 
thus underestimating the prevalence of nitrile production.  GSLs give rise to sulfate and in the 
presence of ferrous ions will also generate sulfur (Figure 1). In the human gut the sulfate 
released by GSL hydrolysis is likely to be reduced to hydrogen sulfide by sulfate-reducing 
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bacteria [50]. Hydrogen sulfide can have negative implications for human health and the 
importance of the diet and microbiota in this respect is poorly understood. The fate of sulfur 
derived from GSLs and DS-GSLs in the human gut is unknown but it seems likely that it will 
undergo reduction to hydrogen sulfide.  
 
Isothiocyanate stability 
As mentioned earlier, the outcome of the bacterial metabolism of GSLs may be influenced by 
the constituents of the growth media. It is quite possible that metal ions present in media may 
affect the nature of the products e.g. ferrous ions may shift GSL hydrolysis towards nitriles. 
Another factor likely to be of importance is the stability of the ITCs in the growth media. 
Various growth media are utilized depending on the bacteria in question and it is possible that 
ITCs can react with some of the media components as well as with components of the cell. 
Previous work has shown ITCs to be unstable in buffers and water [51, 52] while others have 
determined the half-lives of ITC conjugates [53] which is clearly an important factor to 
consider when carrying out quantitative determinations of hydrolytic products .  
 
The analysis of glucosinolate metabolites 
Methods for the analysis of GSLs and their hydrolysis products are well reviewed [54] and 
here we highlight some of the main problems concerning the measurement of GSL 
metabolites in the gut and fermentation models.  During the consumption of Brassica 
vegetables not all of the products of GSLs hydrolysis can be accounted for and ideally the 
yield of ITCs from an intake of brassica vegetables would be 100% thus enabling the full 
potential of these health promoting compounds [55]. In this respect the method of analyzing 
ITCs is important as traditional methods such as GC-MS and LC-MS are likely to 
underestimate ITC concentrations if significant amounts are bound to protein via lysine and 
cysteine residues. Here, alternative methods that measure total ITCs like the 
cylocondensation reaction have been used successfully in a study examining the cecal 
microbiotica of rats fed broccoli powder [56]. This was in contrast to LC-MS/DAD and GC-
MS analysis where no ITCs were detected. Treatment of the samples with excess glutathione 
(GSH) however, enabled the ITCs to be observed as their GSH conjugates on the basis that 
an excess of GSH displaces the ITC from the protein bound conjugates. Methodology has 
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been developed for looking at the protein adducts of 1-methoxy-3-indolylmethyl 
glucosinolate (neoglucobrassicin) metabolites in various organs of mice and this is also 
potentially a valuable  tool in the quantification of ITC protein adducts [57]. The use of 
isotopically labelled GSLs in studying the metabolism of these compounds in animal models 
has been very limited. Studies have been carried out with radiolabelled ITCs and 3,4-
epithiobutanenitrile where these compounds were fed to rats and their disposition and 
pharmokinetics determined [58–60]. While recent advances in LC-MS enables much of the 
metabolism of GSLs to be followed, there is still a great deal of merit in using both 
radiolabelled and stable isotopically labelled GSLs. The use of radiolabelled ITCs has given 
important information on the distribution and pharmokinetics of these compounds but does 
not represent the true picture of GSL metabolism particularly in terms of other products such 
as nitriles. 
1
H NMR has been successfully used to monitor GSL metabolism in a human fecal 
inoculum during an in vitro fermentation [47] and identified two amine products. Figure 4 
shows the metabolism of sinigrin by L. agilis R16 to give predominantly allylisothiocyanate 
in real time (unpublished data) using 
1
H- NMR.  In vivo NMR is a powerful tool [61] to study 




H5]glucoraphanin [62] it is surprising that this GSL has not been utilized in 
metabolism work with humans or animal models where there could be scope for in vivo NMR 
spectroscopy. Other radiolabelled GSLs and stable isotopically labelled GSLs have also been 
synthesised which also would be useful in GSL metabolism studies [63, 64].  
 
Side chain modification 
The range of GSLs tested during fermentations as well the products formed are shown in 
Table 2.  The most commonly examined GSL is sinigrin mostly because of its commercial 
availability and ease of purification from seed material [65]. Glucoraphanin, however, is 
increasingly being used in such studies because of its importance to human health. The 
reduction of sulforaphane to erucin was first observed in a study with rats fed sulforaphane 
where erucin ITC conjugates were detected in bile and urine [66]. More recently the same 
type of transformation has been observed with both glucoraphanin and sulforaphane in a 
human fecal fermentation. During a batch fermentation of glucoraphanin with a human fecal 
inoculum [67] a time dependent decrease in glucoraphanin concentration was observed with a 
corresponding increase in the levels of glucoerucin. This was also evident in the hydrolytic 
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products of the fermentation where sulforaphane and sulforaphane nitrile accounted for less 
than 2% of the total products while erucin and erucin nitrile formed 28% and 67% 
respectively. Thus a major change in the side chain structure occurred as well as the 
formation of nitriles as the dominant products which has implications for the bioactivity of 
glucoraphanin. Work with individual bacterial strains (Table 2) showed both glucoraphanin 
and glucoiberin to be converted to their corresponding reduced form to give glucoerucin and 
glucoiberverin while the hydrolytic products were the corresponding nitriles i.e. erucin nitrile 
and iberverin nitrile [25].  Further work [23] with other bacteria showed the same trend with 
the exception of L. agilis R16 and E. casseliflavus CP1 which could not metabolise 
glucoraphanin or glucoiberin while E. coli VL8 was able to biotransform both of these GSLs 
as well as others (Table 2). It was also observed in this study that both sulforaphane and 
sulforaphane nitrile were able to undergo this conversion to the reduced forms. Using a crude 
cell-free protein extract of E. coli VL8, the reductase activity was shown to be NADPH and 
Mg
2+ 
dependent. Given the importance of glucoraphanin in the diet, the oxidation-reduction 
of the methylsulfinyl alkyl side chain requires more work particularly to see if glucoerucin or 
its corresponding ITC can be re-oxidised in humans. 
Bacterial myrosinase sequences and mechanism of activity 
Almost all plant myrosinases belong to the GH1 family of  β-O-glucosidases and are 
activated by ascorbate [68–70]. Some insect myrosinases have also been characterised in 
particular that from Brevicoryne brassicae which also belongs to the GH1 family of β-O-
glucosidases [71–73]. Most interrogation of the bacterial genomes for identification of 
myrosinase genes have been based on plant myrosinase gene sequences. This was the case for 
recent work with E. coli 0157:H7 where mutations of the putative myrosinase genes were 
generated by gene replacement to confirm the identify [30]. We have used a similar approach 
where the candidate genes from E. casseliflavus CP1 and E. coli VL8 were cloned based on 
sequences from the known genomes of E. casseliflavus NCCP-53 and E. coli O83:H1 NRG 
857C and overexpressed them in E.coli [44] although no myrosinase activity could be 
demonstrated.  
Both plant and aphid myrosinases have been fully characterized  [68, 71]. Mechanistically the 
two enzymes are different with plant myrosinase utilising a glutamic acid as a nucleophile 
with ascorbate [69] acting as a catalytic base while aphid myrosinase functions as a typical β-
O-glucosidase using two glutamate residues without a requirement for ascorbate [73]. To date 
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ascorbate has only had a marginal effect on non-plant myrosinases which is perhaps expected 
since plant myrosinase utilizes ascorbate as a cofactor in the active site as a base whereas 
most β-O-glucosidases use a glutamic acid residue.  
For bacterial myrosinases, little is known concerning the structure of myrosinase with the 
exception of Citrobacter Wye1 where a complete gene sequence has been identified [34]. 
This sequence was based on the actual genome of Citrobacter Wye1 together with an N-
terminal sequence and peptide sequences from tryptic digests of the purified myrosinase. 
Unlike plant and aphid myrosinases this enzyme belongs to the GH3 family of β-O-
glucosidases (InterProt analysis [74]) and the full length myrosinase gene that encodes an N-
terminal signal peptide which presumably targets the protein to the periplasm. Other recent 
work has identified a 6-phospho-β-glucosidase (bglA, ascbB, chbF) which was based on 
homology with plant myrosinase. Gene mutations were carried out and analysed  for their 
ability to metabolise sinigrin and it was found that the genes bglA and ascbB played an 
important role in sinigrin degradation by E. coli 0157:H7  [30]. It would be useful to express 
these genes and undertake detailed characterisation to confirm their role as myrosinases. 
Interestingly the Citrobacter Wye 1 myrosinase has strong homology (70%) with an E. 
cloacae β-O-glucosidase which is known to have myrosinase activity as well as high 
homology with other bacterial β-O-glucosidases. A feature of the GH3 β-O-glucosidase is the 
signature ‘SDW’ conserved motif as is the case for Citrobacter Wye1 myrosinase and 
contains aspartate as the catalytic nucleophile rather than glutamate that is characteristic of 
GH1 plant myrosinases. There was very little homology between the Citrobacter Wye1 and 
plant or aphid myrosinases [34]. If a 6-phospho-β-glucosidase is responsible for the 
metabolism of sinigrin by E. coli 0157:H7 then it is possible that the GSL substrate requires 
phosphorylation at the 6-hydroxyl position on the glucose residue of the GSL (Figure 3). 
ATP-dependent β-glucoside kinases are known and can phosphorylate a range of substrates 
such as the natural products salicin and amygdalin and artificial substrates like iso-propyl-β-
D-thioglucopyranoside [75]. In a recent study using differential proteomics on E. coli VL8,  a 
glucose specific phosphotransferase system was shown to be induced by sinigrin (in 
comparison to a control) which gives some evidence towards a phosphorylation step 
necessary for the hydrolysis of GSLs [76]. Thus, a prerequisite phosphorylation of the 
glucose moiety might explain why it has not been possible to observe myrosinase activity in 
cell-free protein extracts of some of the bacteria such as L. agilis R16 described in this 
review.  
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Diversity of microorganisms able to metabolise glucosinolates  
Despite the limited number of studies on bacterial metabolism of GSLs it is clear that this 
metabolic capacity is not limited to a single phylotype or a family of bacterial species. They 
include members of Firmicutes, Bacteriodetes, Actinomycetes and Proteobacteria. There is 
good evidence to indicate that a high degree of horizontal gene transfer can occur between 
bacterial species in the environment [77, 78] that may explain the observed diversity in 
bacterial groups able to metabolise  the GSLs. The range of bacteria include both Gram 
positive and Gram negative, those that are rods or cocci, commensal and those associated 
with pathogenic traits all have the capacity for GSL biotransformation. Also, the habitat of 
these bacteria is not limited to the GI tract although most of the studies are related to gut 
bacteria for their association with dietary GSLs. They are also found in soil and have been 
isolated from plant sources. No doubt we will find many more relevant bacterial groups as we 
learn more about the gut bacteria and their metabolic capacity in both human and animal GI 
tract.  In this review, we have focused only on bacterial metabolism but it is highly likely that 
in time we will discover other microbes, archaea, yeast and fungi that are able to metabolise 
GSLs. Several studies have already reported the presence of myrosinase in Aspergillus niger 
[79, 80] and other fungi [81, 82].  
 
Conclusions and future work 
In comparison to plants very little work has been carried out on the metabolism of GSLs by 
bacteria. Given the importance of GSLs in the human diet it has become desirable to 
investigate the mechanisms of their biotransformation in the gut particularly with a view to 
increasing ITC production. This requires a much more detailed study to identify those 
bacteria that play a key role in ITC production as well as investigating why nitriles are often 
the end- products. It may well be that ITCs are toxic to the bacteria that produce them and it 
then becomes preferable for NIT production as a form of detoxification as is the case for 
some insects that metabolise GSLs [83]. While specifier proteins that modify the outcome of 
GSL hydrolysis  have been discovered in plants [36] no such proteins have been found in 
bacteria although there is one case of an identified ETN in rat intestinal microbiota [38] 
which suggests the presence of an ESP-like protein although this requires confirmation. The 
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role of sulfatases in GSL metabolism is still unclear although DS-GSL metabolism to nitriles 
has been established and these enzymes require identification to confirm this role.  
Human intervention studies have shown that there is a wide variation in the amount of ITC 
present in the urine and it is thought that this may reflect on differences in the composition of 
the microbiotica of individuals i.e. the ability of microbiota to generate ITCs [84, 85]. These 
studies identified subjects that are low or high secretors of ITCs in their urine  and indeed the 
fecal microbiota of high ITC secretors were more efficient at degrading glucoraphanin than 
those of low ITC secretors. However, using tRFLP, a relatively low resolution molecular 
profiling method, indicated that the gut bacterial communities are altered by consumption of 
cruciferous vegetables in all subjects. It was not possible however, to differentiate the 
composition of the gut microbiota between the two secretor groups [84, 85]. Given that many 
of the identified metabolisers of the GSLs include groups of beneficial bacteria such as the 
lactobacilli and bifidobacteria that are often utilised as probiotics, this opens up potential 
opportunities to exploit such bacteria as dietary supplements with GSL containing foods that 
would provide health benefits particularly to low ITC secreting individuals as part of their 
personalized nutrition. Recently a study has looked at the potential for expressing the 
glucotropaoelin biosynthetic pathway in E. coli together with a myrosinase of B. brevicoryne 
with some success as the authors were able to show the in vitro formation of 
benzylisothiocyanate [86]. If this technology can be developed where ITCs are actually 
produced during fermentation then it could potentially allow the delivery of sulforaphane in 
the gut. However, such heterologous systems would be considered GMO and would require 
regulatory approval.  
Further characterization of bacterial myrosinases should be an important goal in 
understanding product formation from GSL hydrolysis. The sequences of bacterial 
myrosinase genes are likely to be different from plant and aphid myrosinases as was 
demonstrated by the recent characterisation of the Citrobacter Wye1 enzyme [34]. Once 
additional functional bacterial genes have been identified it will open up opportunities for 
genome mining of human and animal gut bacterial metagenomes which are becoming widely 
available as a result many different microbiome sequencing projects.  Approaches to identify 
myrosinase genes should include the determination of genomes together with peptide 
sequence analysis of partially or purified myrosinase. A synthesis of 6-P-GSL would enable 
the possibility of 6-phospho-β-O-glucosidases as myrosinases to be explored. L. agilis R16 
produces large amounts of allylisothiocyanate from sinigrin yet does not inhibit its growth 
www.mnf-journal.com Page 13 Molecular Nutrition & Food Research 
 
This article is protected by copyright. All rights reserved. 
suggesting that the ITC cannot cross its cell wall or it has developed other resistance 
mechanisms. In contrast, Citrobacter Wye1 does not seem to produce allylisothiocyanate in 
vivo but to as yet an unknown molecule which might be a detoxification product or that the 
allylisothiocyanate is unstable. This may also be true of other bacteria and requires a more 
thorough study to determine potential detoxification mechanisms. For example allylamine 
and benzylamine were obtained from sinigrin and glucotropaeolin respectively in a human 
fecal fermentation [47]. During our fermentation work, both with pure bacterial cultures and 
with mixed fecal bacteria we have never observed amines and it would be desirable to 
investigate further the occurrence of these compounds.  
Of interest is the effect that ITC producing bacteria have on other microorganisms of the 
human gut. ITCs are known to have antibacterial properties [87–89] and it is possible that 
there may be an overall negative effect on other functions of the gut microbiota. This 
however, would be dependent on the concentrations of ITCs in the human gut and as yet this 
question has not been fully addressed [56]. A recent study has shown that the microbial 
conversion of GSLs to ITCs can be modified by the frequency of GSL consumption in rats 
and resulted in a change of the microbiota composition [90] which is effectively an 
enrichment process for GSL utilizing bacteria. While some bacteria produce ITCs it is highly 
likely that other bacteria in the human gut will have the potential to detoxify these 
compounds so the situation with the microbiota is likely to be complex.  This raises many 
questions on the importance and efficiency of gut bacteria in the generation of ITCs and 
competing detoxification processes and how this impacts on the bioavailability of ITCs.  
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Figure Legends 
Figure 1. Generalised scheme of the hydrolysis of GSLs by plant myrosinases. RNCS, 
isothiocyanate; RCN, nitrile; RSCN, thiocyanate; ETN, epithionitriles; ESP, epthiospecifier 
protein; TFP, thiocyanate forming protein.  
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Figure 2. Hypothesised route to nitriles via DS-GSLs 
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Figure 3. Generalised structure of a hypothetical 6-P-glucosinolate 
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Figure 4. The metabolism of sinigrin monitored by 1H-NMR over 19 h showing the changes 
in the proton resonances of the alkenyl region of sinigrin and allylisothiocyanate during 
metabolism. 1H-NMR was carried out on a Bruker Avance DRX600 spectrometer, 14.1 T 
magnet and 600MHz proton resonance frequency.  
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Graphic Abstract 
Gut bacteria play an important role in the hydrolysis of dietary glusosinolates to the 
isothiocyanates that are known to have chemoprotective functions. We have yet to fully 
characterise all the bacterial enzymes involved. In the GI tract this hydrolytic process appears 
complex and a number of bacterial metabolic pathways are proposed that result in the 
production of isothiocyanates or nitrile products. 
 
  
www.mnf-journal.com Page 25 Molecular Nutrition & Food Research 
 
This article is protected by copyright. All rights reserved. 
Table 1: In vivo and in vitro fermentations. GSLs used as substrates; 1, sinigrin; 2, 
glucotrapaoelin; 4, glucoraphanin; 5, glucoerucin (* from in vitro interconversion of 
glucoraphanin to glucoerucin). Products 9, allylisothiocyanate; 10, allylnitrile; 15, 
sulforaphane; 16, sulforaphane nitrile; 19, erucin; 20, erucin nitrile; 22, 3,4-
epithiobutanenitrile (3,4-epithiobutanenitrile); 23, allylamine; 24, benzylamine. NT, not 
tested; NA, not available; ND, not detected; OP, other product. 
 Analysis  








 1 9 ND  100 (36 h) [19] 
Rat cecal 
microbiota 
 4 ND trace  100 (24 h) [20] 
Cecal microbiota 
with MRS media 






 1 ND ND 23 100 (30 h) [47] 
  2 ND ND 24 100 (30 h)  
Human in vitro 
intestinal model  
 1 9 ND  100 (12 h) [91] 
Human in vitro 
intestinal model 









 1 9 10  69 (6 h) [38] 
 1 RSM 9 (trace) 10 22   
Lactobacillus 
(LEM 220) Rats 
 RSM NT NT  NA [15] 
E. Coli (EM0)        
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Bacteroides 
vulgatus (BV8H1) 
 RSM NT NT  NA [17] 
 
Table 2: In vitro assessment of pure bacterial strains shown to metabolise GSLs. The 
presence or absence of the typical products i.e. ITC and/or nitrile are indicated. % GSL 
conversion is given as the least to the maximum value for any number of isolates, NT = not 
tested, NA = not available, ND = not detectable. Myr+ = myrosinase activity, Myr- = no 
myrosinase activity. GSLs used as substrates; 1, sinigrin; 2, glucotrapaoelin; 3, 
gluconasturtiin; 4, glucoraphanin; 5, glucoerucin; 6, glucoiberin; 7, sinalbin; 8, progoitrin. 
Products; 9, allylisothiocyanate; 10, allylnitrile; 11, benzylnitrile; 12, benzylisothiocyanate; 
13, phenethyl nitrile; 14, phenethylisothiocyanate; 15, sulforaphane; 16, sulforaphane nitrile; 
17, iberverin; 18, iberverin nitrile; 19, erucin; 20, erucin nitrile; 21, goitrin.  RSM = rape seed 
meal GSL extract products i.e. ITC and/or nitrile are indicated. 1, DS-sinigrin; 2, DS-
glucotrapaoelin; 3, DS-gluconasturtiin; 4, DS- glucoraphanin; 5, DS-glucoerucin.  Products: 




  Fermentation Cell free protein extract 
Bacterial species  Gram 
+/- 
GSL ITC NIT % GSL 
conversion 







          
           
          
Citrobacter WYE1  - 1 ND ND 100 1,2,3,4 9, 
Myr+ 
ND [34] 
Bacillus (isolates)       + 1 NT NT 74/91/62/56 NT   [21] 
Pseudomonas - 1 NT NT NA NT   [21] 
Lactobacillus    + 1 NT NT NA NT   [21] 
Lactobacillus  (LEM) + 1 NT NT 13-28 (5 d) NT   [15] 
  8 NT NT 13-20 (5 d) NT   [15] 
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Streptomyces 
(isolates) 
+ 1 NT NT 43-67 NT   [21] 
Staphylococcus + 1 NT NT 77 NT   [21] 
Lactobacillus agilis 
R16 
+ 1 9 10 100 1 Myr-  [22, 
24]  
  5 19 20 100 NT   [23] 
  6 ND ND 11 NT   [23] 
  4 ND ND 10 NT   [23] 
  2 12 11 90 NT   [24] 
  3 14 ND 95 NT   [24] 
Enterococcus 
casseliflavus CP1 
+ 1 9 10 100 1 Myr-  [24] 
  5 19 20 100 NT   [23] 
  6 trace ND 41 NT   [23] 
  4 ND trace 53 NT   [23] 
  2 12 11 90 NT   [24] 
  3 14 13 100 NT   [24] 
Eschericha coli VL8 - 1 9 10 90 1 Myr-  [24] 
  5 19 20 100 NT   [23] 
  6 17 18 87 NT   [23] 
  4 15 16 91 NT   [23] 
  2 12 11 100 NT   [24] 
  3 14 13 100 NT   [24] 
  Fermentation Cell free protein extract 
Lactobacillus 
plantarum KW30 
+ 4,6 ND 16,18,20 30-33  NT   [25] 
Lactococcus lactis. 
Subsp. Lactis KF147 
+ 4,6 ND 16,18,20 30-33 NT   [25] 
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Escheria coli Nissle 
1917 
- 4,6 ND 16,18 65-78 NT   [25] 
Enterobacter 
cloacae 
- 4,6 ND 16,18 65-78 NT   [25]  
Enterobacter 
cloacae 







- 1 NT NT NA 1 Myr 
+ 
 [31] 
Bacillus cereus 10X + RSM 21 NT NA NT   [92] 
Bacillus cereus St3          
Lactobacillus 
gasseri 
+ 4 ND 16 36-49  NT   [26] 
Lactobacillus 
acidophilus 
+ 4 ND 16 36-49 NT   [26] 
Lactobacillus casei + 4 ND 16 36-49 NT   [26] 
Lactobacillus 
plantarum 
+ 4 ND 16 36-49 NT   [26] 
Bifidobacterium 
pseudocatenulatum 








with GSL (2) 
NT   [27] 
Bifidobacterium 
adolescents 
+ 1 ND 10  9  [27] 
Bifidobacterium 
adolescents 
 2 ND 11 NT   [27] 
Bifidobacterium 
longum 




- 1 9 ND 100 (36 h) NT   [19] 
E. coli (various 
strains) 
- 8 21 NT 3-26 (48 h) NT   [14] 
Paracolobactrum 
aerogenoides 
- 8 21 NT 24-81 (48 h) 8 21 NT [14] 
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Aerobacter 
aerogenes  
+ 8 21 NT 26-28 (48 h) NT   [14] 
Bacillus subtilis + 8 21 NT 59-72 (48 h) NT   [14] 
Staphylococcus 
epidermis 
+ 8 21 NT 19 (48 h) NT   [14] 
Proteus vulgaris - 8 21 NT 42-48 (48 h) NT   [14] 








+ 7 NT NT 0.6-4 (6 d) NT   [28] 




- 7 NT NT 5.02-11.3 (6 
d) 




+ 7 NT NT 6.06-10 (6 d) NT   [28] 
Pediococcus 
acidilactici 
+ 7 NT NT 2.92-3.16 (6 
d) 
NT   [28] 
Pediococcus 
pentosaceus 
+ 1 9 NT 11.99 (12 d)  NT   [29] 
E. coli 0157:H7 - 1 9 NT 38.96 (12 d) NT   [29] 
Listeria 
monocytogenes  
+ 1 9 NT 19.04 (8 d) NT   [29] 
Escherichia  fecalis + 1 9 NT 9.05 (12 d) NT   [29] 
Staphylococcus  
aureus 
+ 1 9 NT 20.39 (8 d) NT   [29] 
Staphylococcus 
carnosus 
+ 1 9 NT 21.2 (8 d) NT   [29] 
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Salmonella 
typhimurium 
- 1 9 NT 28.02 (12 d) NT   [29] 
Pseudomonas 
fluorescens 
- 1 9 NT 7.17 (12 d) NT   [29] 
Listeria 
monocytogenes 
+ 1 9 NT 53.2 (21 d, 
21oC) 
NT   [93] 
Salmonella  - 1 9 NT 59.9 (21 d, 
21oC) 
NT   [93] 
 
 
 
